ID: ALA1794796

Max Phase: Preclinical

Molecular Formula: C6H13NO4

Molecular Weight: 163.17

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  OC[C@@H](O)[C@H]1NC[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C6H13NO4/c8-2-4(10)5-6(11)3(9)1-7-5/h3-11H,1-2H2/t3-,4-,5-,6-/m1/s1

Standard InChI Key:  RVNSAAIWCWTCTJ-KVTDHHQDSA-N

Associated Targets(non-human)

Alpha-mannosidase 2C1 19 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 163.17Molecular Weight (Monoisotopic): 163.0845AlogP: -2.97#Rotatable Bonds: 2
Polar Surface Area: 92.95Molecular Species: BASEHBA: 5HBD: 5
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 5#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.16CX Basic pKa: 9.04CX LogP: -2.89CX LogD: -4.53
Aromatic Rings: 0Heavy Atoms: 11QED Weighted: 0.30Np Likeness Score: 2.48

References

1. Winkler DA, Holan G..  (1989)  Design of potential anti-HIV agents. 1. Mannosidase inhibitors.,  32  (9): [PMID:2504921] [10.1021/jm00129a011]

Source